Sponsor
Ablative Solutions, Inc.
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Ablative Solutions, Inc. appears in 5 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
5 shownRenal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)NCT07083765 · lead sponsor · 2026-10-01
NOT_YET_RECRUITINGTARGET BP I Clinical TrialNCT02910414 · lead sponsor · 2019-07-22
ACTIVE_NOT_RECRUITINGThe TARGET BP OFF-MED TrialNCT03503773 · lead sponsor · 2018-09-24
COMPLETEDThe Peregrine Post-Market Study for the Treatment of HypertensionNCT02570113 · lead sponsor · 2015-11-01
COMPLETEDThe Peregrine Study: A Safety and Performance Study of Renal DenervationNCT02155790 · lead sponsor · 2014-07-01
COMPLETEDSponsor roles
lead sponsor5
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.